Horizon Therapeutics Public Ltd Co — Operating Income by Fiscal Year

14 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/07e7acf4-2cf8-47c3-94cd-c692c617b51c/serie/operating-income

Fiscal year	Operating Income	Period	Evidence
FY 2022	$617.4M	2022-01-01 – 2022-12-31	evidence 0000950170-23-005337
FY 2021	$543.1M	2021-01-01 – 2021-12-31	evidence 0001564590-22-007863
FY 2020	$490.0M	2020-01-01 – 2020-12-31	evidence 0001564590-21-007818
FY 2019	$126.6M	2019-01-01 – 2019-12-31	evidence 0001564590-20-006575
FY 2018	$37.9M	2018-01-01 – 2018-12-31	evidence 0001564590-20-006575
FY 2017	$-339.5M	2017-01-01 – 2017-12-31	evidence 0001564590-20-006575
FY 2016	$-145.9M	2016-01-01 – 2016-12-31	evidence 0001564590-19-004667
FY 2015	$55.4M	2015-01-01 – 2015-12-31	evidence 0001564590-16-013652
FY 2014	$-8.5M	2014-01-01 – 2014-12-31	evidence 0001193125-15-067257
FY 2013	$-42.9M	2013-01-01 – 2013-12-31	evidence 0001193125-14-096677
FY 2012	$-78.9M	2012-01-01 – 2012-12-31	evidence 0001193125-13-111071
FY 2011	$-120.6M	2011-01-01 – 2011-12-31	evidence 0001193125-12-129945
FY 2010	$-43.8M	2010-01-01 – 2010-12-31	evidence 0001193125-12-129945
FY 2009	$-18.8M	2009-01-01 – 2009-12-31	evidence 0001193125-12-129945

Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Horizon Therapeutics Public Ltd Co — all facts · Revenue · Net Income